Desensitisation of β2-adrenoceptor-mediated responses by long-acting β2-agonists in human lung mast cells

被引：0
|
作者：
Scola, A [1 ]
Chong, LK [1 ]
Peachell, PT [1 ]
机构：
[1] Univ Sheffield, Royal Hallamshire Hosp, Sect Mol Pharmacol & Pharmacogenet, Sheffield S10 2JF, S Yorkshire, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2002年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
266P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Desensitisation of β2-adrenoceptor-mediated responses by salbutamol and salmeterol in human lung mast cells
    Scola, A
    Chong, LK
    Peachell, PT
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U68 - U68
  • [2] Desensitization β2-adrenoceptor-mediated responses by shortacting β2-adrenoceptor agonists in human lung mast cells
    Chong, LK
    Suvarna, K
    Chess-Williams, R
    Peachell, PT
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (03) : 512 - 520
  • [3] Influence of agonist intrinsic activity on the desensitisation of β2-adrenoceptor-mediated responses in mast cells
    Scola, AM
    Chong, LK
    Williams, RC
    Peachell, PT
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (01) : 71 - 80
  • [4] Desensitisation of mast cell β2-adrenoceptor-mediated responses by salmeterol and formoterol
    Scola, AM
    Chong, LK
    Suvarna, SK
    Chess-Williams, R
    Peachell, PT
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (01) : 163 - 171
  • [5] Influence of β2-adrenoceptor gene polymorphisms on β2-adrenoceptor-mediated responses in human lung mast cells
    Kay, L. J.
    Rostami-Hodjegan, A.
    Suvarna, S. K.
    Peachell, P. T.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (03) : 323 - 331
  • [6] Benefits of long-acting β2-agonists
    Lipworth, Brian J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : 725 - 725
  • [7] Pharmacogenomics of long-acting β2-agonists
    Blake, Kathryn
    Lima, John
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (11) : 1733 - 1751
  • [8] New long-acting β2-agonists
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (09) : 1385 - 1388
  • [9] Safety Trials of Long-Acting β2-Agonists
    Weinberger, Miles
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1481 - 1482
  • [10] Benefits of long-acting β2-agonists -: Reply
    Gibson, Peter G.
    Ducharme, Francine M.
    Cates, Christopher Joseph
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : 726 - 726
12345